AKYA — Akoya Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $202.95m
- $196.61m
- $96.63m
- 55
- 27
- 56
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14.8 | -16.7 | -42.9 | -70.6 | -63.3 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -0.859 | 3.65 | 6.79 | 7.8 | 15.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.38 | 2.39 | -4.56 | 2.16 | -12.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -13.8 | -6.84 | -36.1 | -53.5 | -50.9 |
Capital Expenditures | -2.87 | -3.29 | -5.09 | -7.36 | -3.65 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -10 | 10 | 0 | -6.72 | 7 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -12.9 | 6.73 | -5.09 | -14.1 | 3.35 |
Financing Cash Flow Items | -1.23 | -4.42 | 137 | -2.35 | -2.04 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 28.6 | 5.49 | 137 | 28.7 | 56.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.89 | 5.37 | 95.9 | -38.8 | 9.29 |